Literature DB >> 24644045

Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.

Veronika Fedirko1, Talita Duarte-Salles, Christina Bamia, Antonia Trichopoulou, Krasimira Aleksandrova, Dimitrios Trichopoulos, Elisabeth Trepo, Anne Tjønneland, Anja Olsen, Kim Overvad, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Marina Kvaskoff, Tilman Kühn, Annie Lukanova, Heiner Boeing, Brian Buijsse, Eleni Klinaki, Chrysanthi Tsimakidi, Alessio Naccarati, Giovanna Tagliabue, Salvatore Panico, Rosario Tumino, Domenico Palli, H Bas Bueno-de-Mesquita, Peter D Siersema, Petra H Peters, Eiliv Lund, Magritt Brustad, Karina Standahl Olsen, Elisabete Weiderpass, Raul Zamora-Ros, María-José Sánchez, Eva Ardanaz, Pilar Amiano, Carmen Navarro, J Ramón Quirós, Mårten Werner, Malin Sund, Björn Lindkvist, Johan Malm, Ruth C Travis, Kay-Tee Khaw, Magdalena Stepien, Augustin Scalbert, Isabelle Romieu, Pagona Lagiou, Elio Riboli, Mazda Jenab.   

Abstract

UNLABELLED: The association between vitamin D status and hepatocellular carcinoma (HCC) has not been well investigated, despite experimental evidence supporting an important role of vitamin D in liver pathophysiology. Our objective was to investigate the association between prediagnostic circulating 25-hydroxyvitamin D [25(OH)D] serum levels and the risk of HCC in a prospective, nested case-control study among 520,000 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Each case (n = 138) diagnosed between 1992 and 2010 was matched to one control by age, sex, study center, date and time of blood collection, and fasting status. Serum baseline levels of 25(OH)D were measured by liquid chromatography/tandem mass spectrometry. Multivariable incident rate ratios (IRRs) of HCC associated with continuous (per 10 nmol/L) or categorical levels (tertiles or a priori-defined categories) of prediagnostic 25(OH)D were calculated using conditional logistic regression. Higher 25(OH)D levels were associated with a 49% reduction in the risk of HCC (highest versus lowest tertile: multivariable IRR = 0.51, 95% confidence interval [CI], 0.26 to 0.99; Ptrend  = 0.04; per 10 nmol/L increase: IRR = 0.80, 95% CI, 0.68-0.94). The finding did not vary substantially by time from enrolment to diagnosis, and did not change after adjustment for biomarkers of preexisting liver damage, nor chronic infection with hepatitis B or C viruses. The findings were not modified by body size or smoking status.
CONCLUSION: In this prospective study on western European populations, serum levels of 25(OH)D were inversely associated with the risk of HCC. Given the rising incidence of this cancer in low-risk developed countries and the strong public health interest surrounding the potentially cancer-protective roles of vitamin D, additional studies in different populations are required.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24644045     DOI: 10.1002/hep.27079

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  46 in total

Review 1.  Vitamin D and Gastrointestinal Cancers: A Narrative Review.

Authors:  Hemant Goyal; Abhilash Perisetti; M Rubayat Rahman; Avi Levin; Giuseppe Lippi
Journal:  Dig Dis Sci       Date:  2018-12-03       Impact factor: 3.199

2.  Long follow-up time and different sensitivities of cancer types may have obscured the effect of 25-hydroxyvitamin D on cancer incidence and mortality rates.

Authors:  William B Grant
Journal:  Am J Clin Nutr       Date:  2015-07       Impact factor: 7.045

Review 3.  Is That Possible to Stop or Cease the NASH to Turn into HCC?

Authors:  Ahmet Uygun
Journal:  J Gastrointest Cancer       Date:  2017-09

Review 4.  Nutrition and Hepatocellular Cancer.

Authors:  Kerstin Schütte; Christian Schulz; Peter Malfertheiner
Journal:  Gastrointest Tumors       Date:  2015-11-18

5.  Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort.

Authors:  Marion Carayol; Michael F Leitzmann; Pietro Ferrari; Raul Zamora-Ros; David Achaintre; Magdalena Stepien; Julie A Schmidt; Ruth C Travis; Kim Overvad; Anne Tjønneland; Louise Hansen; Rudolf Kaaks; Tilman Kühn; Heiner Boeing; Ursula Bachlechner; Antonia Trichopoulou; Christina Bamia; Domenico Palli; Claudia Agnoli; Rosario Tumino; Paolo Vineis; Salvatore Panico; J Ramón Quirós; Emilio Sánchez-Cantalejo; José María Huerta; Eva Ardanaz; Larraitz Arriola; Antonio Agudo; Jan Nilsson; Olle Melander; Bas Bueno-de-Mesquita; Petra H Peeters; Nick Wareham; Kay-Tee Khaw; Mazda Jenab; Timothy J Key; Augustin Scalbert; Sabina Rinaldi
Journal:  J Proteome Res       Date:  2017-08-11       Impact factor: 4.466

Review 6.  The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples.

Authors:  Mads V Lind; Otto I Savolainen; Alastair B Ross
Journal:  Eur J Epidemiol       Date:  2016-05-26       Impact factor: 8.082

7.  25-OH-vitamin D deficiency identifies poor tumor response in hepatocellular carcinoma treated with transarterial chemoembolization.

Authors:  Y-Q Wu; W-Z Fan; M Xue; J Guo; J-L Wei; Y Wang; W Yao; Y Zhao; J-P Li
Journal:  Clin Transl Oncol       Date:  2019-06-10       Impact factor: 3.405

8.  Therapeutic Efficacy of Vitamin D in Experimental c-MET-β-Catenin-Driven Hepatocellular Cancer.

Authors:  Akiko Matsuda; Kaori Ishiguro; Irene K Yan; Tushar Patel
Journal:  Gene Expr       Date:  2018-08-29

9.  Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC Study.

Authors:  Gabriel Y Lai; Jian-Bing Wang; Stephanie J Weinstein; Dominick Parisi; Ronald L Horst; Katherine A McGlynn; Satu Männistö; Demetrius Albanes; Neal D Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-05-02       Impact factor: 4.254

Review 10.  Vitamin D3 from Ultraviolet-B Exposure or Oral Intake in Relation to Cancer Incidence and Mortality.

Authors:  William B Grant; Meis Moukayed
Journal:  Curr Nutr Rep       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.